Amsterdam, October 22, 2007 – Elsevier, leading publisher of scientific, technical and medical (STM) information, today announced that it has added more development-partner-tested features on its ScienceDirect platform. Now well integrated in ScienceDirect product development, the development partners’ involvement has ensured that the new features mirror researchers’ needs.
“We are helping to foster scientific discovery by implementing new functionality that improves ways in which researchers find relevant content,” explains Joep Verheggen, Director, ScienceDirect. “Our ‘Related Articles’ function broadens the initial search by automatically generating similar research results and our new spell checker saves time on re-entering search queries.”
Through intelligent document matching, Related Articles automatically displays citation information and the abstract – including a link to the full text – of content relevant to the article being accessed. This improves the discoverability of information and makes it easier for a researcher to find key information.
To maximize search outcomes and eliminate unwanted results, a new Fast Search & Transfer™ (FAST) spell check function has been integrated into ScienceDirect. The spell checker recognizes spelling errors using a built-in dictionary.
As an added value to traditional abstracts, ScienceDirect is now indexing Graphical Abstracts of 30 chemistry titles. Particularly important to organic* chemistry researchers, Graphical Abstracts help researchers to summarize the scope of a structure or reaction more succinctly than plain text.
For more information on the latest additions to ScienceDirect, please visit: http://www.sciencedirect.info/news/releases/
*Also of relevance to several other fields of chemistry, such as inorganic and materials chemistry.
About ScienceDirect
Over a quarter of the world's full text scientific, technical and medical (STM) articles - managed by renowned editors, written by respected authors and read by researchers from around the globe - are available in one place: ScienceDirect (http://www.sciencedirect.com).
Elsevier's extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over eight million articles are available online, including Articles in Press which offer rapid access to recently accepted manuscripts. The critical mass of information available on ScienceDirect is unsurpassed. Coverage includes over 2,000 journals published by Elsevier and dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. An expanding program of online major reference works, handbooks, book series and e-Books in all fields of science seamlessly interlinks with primary research referenced in journal articles.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).